TAMI BIESENTHAL: Open Payments
NPI 1346469756 · CLOVIS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 14 payments from 8 companies in 2025. Trend: 2023 $159 · 2024 $332 · 2025 $333
Food & beverage: $333
| Company | Payments | Amount |
|---|---|---|
| Caris MPI, Inc. | 3 | $87 |
| AstraZeneca Pharmaceuticals LP | 3 | $71 |
| Tempus AI, Inc | 2 | $50 |
| Integra LifeSciences Corporation | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| Fennec Pharmaceuticals, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $22 |
| Tactile Systems Technology Inc | 1 | $17 |
Products named: MI CANCER SEEK, LYNPARZA, XT CDX, CODMAN CERTAS, KEYTRUDA, Fyarro, Lenvima, Flexitouch Plus.
Industry payments across CA — which companies pay providers there.
